Alpa Laboratories Ltd. Regulatory Clarification
Alpa Laboratories Limited has provided a clarification to the National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Limited (BSE) regarding the submission of its revised consolidated financial results in XBRL format.
Date and Nature of Exchange Query
- The company received a communication from the exchanges dated July 23, 2026.
- The query concerned discrepancies identified in the Consolidated Financial Results submitted in XBRL format for the period ended March 31, 2026.
Company's Clarification on Trading Volume and Financial Results
- The company submitted revised Consolidated Financial Results in XBRL on July 23, 2026.
- The revision was made to rectify an inadvertent error present in the earlier XBRL filing.
- The specific correction ensured that the Profit Before Tax (PBT) figure reported in the revised XBRL filing is now fully aligned with the figures appearing in the signed PDF version of the Consolidated Financial Results, which had already been submitted to the exchanges.
- The submission was made with NSE NEAPS Application Number 177314 and BSE Acknowledgment Number 2307202605431527.
Details of Financial Results Clarification
The document does not provide specific numerical details of the financial results or the nature of the initial PBT discrepancy. It confirms only that the XBRL data has been corrected to match the approved PDF version.
Topic Tags: Regulatory Response, Financial Results Clarification, Compliance, XBRL Filing